On ECHEMI
Home > Drugs > Pituitary tumor
Pituitary tumor
Pituitary adenoma is a benign adenoma, which is quite common, with 1 case in 100,000 people. In recent years, there has been an increasing trend, especially in women of childbearing age. Beijing Neurosurgery Institute reported that pituitary adenoma accounts for 12.2% of intracranial tumors. The pituitary gland is located in the sella fossa at the base of the skull. The upper part is the sella septum, which separates the optic chiasm and the bottom of the third ventricle, and the lower part is the sphenoid sinus. The pituitary stalk passes through the sella septum, connecting the hypothalamus and the pituitary gland. The pituitary stalk is composed of blood vessels and nerves. The pituitary gland is flanked by venous cavernous sinuses, through which the internal carotid artery, oculomotor nerve, trochlear nerve, abducens nerve and the first junction of the trigeminal nerve pass.
Related Drugs
Vinblastine Sulfate
Indication: It is mainly used for the treatment of solid tumors. It has good effects on malignant lymphoma, testicular tumors, choriocarcinoma, lung cancer, breast cancer, ovarian cancer, skin cancer, Wilms tumor and monocytic leukemia. It can also be used to treat Hodgkin's disease and malignant lymphoma, and choriocarcinoma and breast cancer.
Manufacturer:

Guangzhou Hanfang Pharmaceutical Company Limited

Carmustine Injection
Indication: Because it can pass through the blood-brain barrier, it is effective against brain tumors (malignant glioma, brain stem glioma, medulloblastoma, astrocytoma, ependymoma), brain metastases and meningeal leukemia, malignant lymphoma, multiple myeloma, and in combination with other drugs, malignant melanoma.
Sodium Lactate Injection
Indication: Used to correct metabolic acidosis, buffer in peritoneal dialysis fluid, hyperkalemia with severe arrhythmia and widened QRS wave.
Manufacturer:

Wuhan Binhu Shuanghe Pharmaceutical Co., Ltd.

Lanreotide Acetate for Injection
Indication: 1. Active acromegaly, including patients whose serum GH level does not reach normal level after surgery for pituitary GH tumors, and after external pituitary irradiation radiotherapy. 2. Patients whose serum GH level is still elevated before the full therapeutic effect is achieved, and before surgery for pituitary tumors in some cases. 3. Severe diarrhea, flushing, electrolyte imbalance, exudative polymorphic rash caused by gastrointestinal neuroendocrine tumors and carcinoid syndrome, and AIDS-related diarrhea.
Lanreotide Acetate for Injection
Indication: 1. Active acromegaly, including patients whose serum GH level does not reach normal level after surgery for pituitary GH tumors, and after external pituitary irradiation radiotherapy. 2. Patients whose serum GH level is still elevated before the full therapeutic effect is achieved, and before surgery for pituitary tumors in some cases. 3. Severe diarrhea, flushing, electrolyte imbalance, exudative polymorphic rash caused by gastrointestinal neuroendocrine tumors and carcinoid syndrome, and AIDS-related diarrhea.
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.